Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury.
作者： Lei Yu , Xue-ke Zhao , Ming-liang Cheng , Guo-zhen Yang , Bi Wang
DOI: 10.1038/S41598-017-01271-9
关键词:
摘要: Growing evidence has shown that gut microbiome is a key factor involved in liver health. Therefore, gut microbiota modulation with probiotic bacteria, such as Saccharomyces boulardii, …
nature.com
harvard.edu
sci-hub.se 参考文章(46)
H. Szajewska, M. Kołodziej, Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology & Therapeutics. ,vol. 42, pp. 793- 801 ,(2015) , 10.1111/APT.13344
Nan Qin, Fengling Yang, Ang Li, Edi Prifti, Yanfei Chen, Li Shao, Jing Guo, Emmanuelle Le Chatelier, Jian Yao, Lingjiao Wu, Jiawei Zhou, Shujun Ni, Lin Liu, Nicolas Pons, Jean Michel Batto, Sean P Kennedy, Pierre Leonard, Chunhui Yuan, Wenchao Ding, Yuanting Chen, Xinjun Hu, Beiwen Zheng, Guirong Qian, Wei Xu, S Dusko Ehrlich, Shusen Zheng, Lanjuan Li, None, Alterations of the human gut microbiome in liver cirrhosis Nature. ,vol. 513, pp. 59- 64 ,(2014) , 10.1038/NATURE13568
Fabiana da Conceição Pereira Tiago, Flaviano dos Santos Martins, ELS Souza, Paulo Filemon Paolucci Pimenta, Helena Rocha Corrêa Araújo, Ieso de Miranda Castro, Rogélio Lopes Brandão, Jacques R Nicoli, Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics Journal of Medical Microbiology. ,vol. 61, pp. 1194- 1207 ,(2012) , 10.1099/JMM.0.042283-0
R. Todd Stravitz, David J. Kramer, Management of acute liver failure. Nature Reviews Gastroenterology & Hepatology. ,vol. 6, pp. 542- 553 ,(2009) , 10.1038/NRGASTRO.2009.127
Shenghua Gu, Dandan Chen, Jin-Na Zhang, Xiaoman Lv, Kun Wang, Li-Ping Duan, Yong Nie, Xiao-Lei Wu, Bacterial Community Mapping of the Mouse Gastrointestinal Tract PLoS ONE. ,vol. 8, pp. e74957- ,(2013) , 10.1371/JOURNAL.PONE.0074957
ThierryF Vandamme, Use of rodents as models of human diseases. Journal of Pharmacy and Bioallied Sciences. ,vol. 6, pp. 2- 9 ,(2014) , 10.4103/0975-7406.124301
Tiphaine Le Roy, Marta Llopis, Patricia Lepage, Aurélia Bruneau, Sylvie Rabot, Claudia Bevilacqua, Patrice Martin, Catherine Philippe, Francine Walker, André Bado, Gabriel Perlemuter, Anne-Marie Cassard-Doulcier, Philippe Gérard, Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice Gut. ,vol. 62, pp. 1787- 1794 ,(2013) , 10.1136/GUTJNL-2012-303816
Ruben G.J. Visschers, Misha D. Luyer, Frank G. Schaap, Steven W.M. Olde Damink, Peter B. Soeters, The gut-liver axis Current Opinion in Clinical Nutrition and Metabolic Care. ,vol. 16, pp. 576- 581 ,(2013) , 10.1097/MCO.0B013E32836410A4
Ming Li, Lin Zhu, Ao Xie, Jieli Yuan, Oral Administration of Saccharomyces boulardii Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Reducing Intestinal Permeability and Modulating Gut Microbial Composition Inflammation. ,vol. 38, pp. 170- 179 ,(2015) , 10.1007/S10753-014-0019-7
Marialena Mouzaki, Elena M. Comelli, Bianca M. Arendt, Julia Bonengel, Scott K. Fung, Sandra E. Fischer, Ian D. McGilvray, Johane P. Allard, Intestinal Microbiota in Patients With Nonalcoholic Fatty Liver Disease Hepatology. ,vol. 58, pp. 120- 127 ,(2013) , 10.1002/HEP.26319